August 21, 2014 2:40 AM ET

Pharmaceuticals

Company Overview of Prevacus, Inc.

Company Overview

Prevacus, Inc., a drug development company, is engaged in the prevention and treatment of mild traumatic brain injury or concussion. It provides Prevasol nasal spray, which is used to reduce edema, inflammation, and oxidative stress. The company was founded in 2012 and is based in Tallahassee, Florida.

2035 East Paul Dirac Drive

Suite 106

Innovation Park

Tallahassee, FL 32310

United States

Founded in 2012

Phone:

850-544-2962

Key Executives for Prevacus, Inc.

Founder and Lead Scientific Consultant
Executive Advisor
Age: 54
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Chase Pharmaceuticals Corporation, Inc. United States
Zacharon Pharmaceuticals, Inc. United States
Drug Source Company, LLC United States
Sun Ten Laboratories Inc. United States
Sigma Tau Pharmasource, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Prevacus, Inc., please visit www.prevacus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.